Publication Type: Article
Journal Name: Health Affairs
Full Citation: Amin T, Kesselheim, AS. Secondary patenting could extend US market exclusivity of HIV drugs Norvir and Kaletra through 2028. Health Affairs, 2012;31:2286-2294.
External Link: http://content.healthaffairs.org/content/31/10/2286.abstract
Project: Sources of Transformative Innovation in Medication Development
People: Aaron Kesselheim